Cleveland Biolabs

73 High St
Buffalo, NY 14203

Cleveland Biolabs News

Entolimod candidate granted U.S. patent extension

Tuesday, Dec 1, 2015 @ 7:21pm by BioPrepWatch Reports

Cleveland BioLabs, Inc. (CBL) was granted an extended patent protection for its entolimod candidate radiation countermeasure and oncological therapeutic on Monday.
Read More »

Cleveland Biolabs receives DOD funding recommendation

Friday, Apr 17, 2015 @ 1:21pm by BioPrepWatch Reports

Medical radiation countermeasure candidate shows promise in initial animal studies.
Read More »

Cleveland Biolabs to report on current work at BIO conference

Thursday, Feb 5, 2015 @ 3:49pm by BioPrepWatch Reports

Cleveland Biolabs said on Thursday that it will present data on its oncology and bio-defense programs next week at the 2015 BIO CEO & Investor Conference in New York.
Read More »